Investor Mylan. The Investor Relations website contains information about Mylan N.V.'s business for stockholders, potential investors, and financial...
Investor Mylan. The Investor Relations website contains information about Mylan N.V.'s business for stockholders, potential investors, and financial...
What’s new on Investor.mylan.com: Check updates and related news right now. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Investor.mylan.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.
HERTFORDSHIRE, England, PITTSBURGH and BENGALURU, India, June 3, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced the presentation of data from the HERITAGE study at the 2016 American...
HERTFORDSHIRE, England and PITTSBURGH, Jan. 8, 2016 /PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL) today announced that it has entered into an exclusive global collaboration agreement with Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) to develop, manufacture...
Bengaluru, Karnataka, India Biocon Ltd. (BSE code: 532523, NSE: BIOCON) and Mylan N.V. (NASDAQ, TASE: MYL) today announced that the U.S. Food and Drug Administration (FDA) has accepted Mylan’s biologics license application (BLA) for MYL-1401O, a proposed...
Mylan, the maker of the EpiPen brand of epinephrine auto-injector, announced this morning that they would begin marketing a generic version of the device identical to the brand name version beginning in a few weeks. The device will carry a wholesale...
Mylan Inc., one of the world’s leading pharmaceutical companies, and the Elton John AIDS Foundation (EJAF) announced that they will give a combined $1 million to the Business Leadership Council for a Generation Born HIV Free (BLC) for the elimination...
Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva® Tablets
Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Mylan and Biocon Receive Positive CHMP Opinion for Semglee™, Biosimilar Insulin Glargine
Mylan to Complete $1 Billion Share Repurchase Plan
Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA® (aflibercept)
MiniWrites – A hub for your creative projects!
A hub for your creative projects!
SOCRATES Journal is an international, refereed, and indexed scholarly publication focused on public policy, administration, and ph...
Past Events & Presentations | Mylan N.V.
The Investor Relations website contains information about Mylan N.V.'s business for stockholders, potential investors, and financial analysts.
Mylan Investor Relations | Mylan N.V.
Discover Viatris Mylan is now part of Viatris, a new global healthcare company committed to empowering people to live healthier at every stage of life. Although this Mylan site remains active for no...
Registrant's telephone number, including area code: 412-232-0100 Securities registered pursuant to Section 12(b) of the Act: Name of Each Exchange...
29 years
Domain age
N/A
Visit duration
N/A
Daily visitors
N/A
Bounce rate
N/A
Child safety
Good
Trust
Good
Privacy
69.2 %
USA